Deutsche Bank
DSGN icon

Deutsche Bank’s Design Therapeutics DSGN Stock Holding History

Deutsche Bank’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
30,613
+9,969
+48% +$124K ﹤0.01% 2838
2026
Q1 		$220K Buy
20,644
+5,103
+33% +$51.6K ﹤0.01% 2967
2025
Q4 		$146K Buy
+15,541
New +$122K ﹤0.01% 3161
2025
Q3 		– Sell
-28,094
Closed -$94.7K – 3631
2025
Q2 		$94.7K Sell
28,094
-35
-0.1% -$131 ﹤0.01% 3280
2025
Q1 		$109K Buy
28,129
+35
+0.1% +$167 ﹤0.01% 3165
2024
Q4 		$173K Hold
28,094
– – ﹤0.01% 3132
2024
Q3 		$151K Hold
28,094
– – ﹤0.01% 3052
2024
Q2 		$94.1K Hold
28,094
– – ﹤0.01% 3136
2024
Q1 		$113K Hold
28,094
– – ﹤0.01% 3113
2023
Q4 		$74.4K Buy
28,094
+27,585
+5,419% +$63.2K ﹤0.01% 3343
2023
Q3 		$1.2K Sell
509
-15,392
-97% -$71.8K ﹤0.01% 3654
2023
Q2 		$100K Sell
15,901
-8,955
-36% -$54.8K ﹤0.01% 3274
2023
Q1 		$143K Buy
24,856
+7,015
+39% +$52.5K ﹤0.01% 3173
2022
Q4 		$183K Buy
17,841
+4,082
+30% +$55.3K ﹤0.01% 3026
2022
Q3 		$230K Sell
13,759
-2,261
-14% -$45K ﹤0.01% 2867
2022
Q2 		$224K Buy
16,020
+1,230
+8% +$16.6K ﹤0.01% 3097
2022
Q1 		$239K Sell
14,790
-2,228
-13% -$34.1K ﹤0.01% 3163
2021
Q4 		$364K Buy
17,018
+9,003
+112% +$155K ﹤0.01% 3031
2021
Q3 		$118K Buy
8,015
+15
+0.2% +$249 ﹤0.01% 3831
2021
Q2 		$159K Buy
+8,000
New +$202K ﹤0.01% 3916

Other funds holding DSGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank's DSGN Position: Q2 2026 in Review

Deutsche Bank increased its Design Therapeutics (DSGN) stake by 48% in Q2 2026, buying an estimated $124K and bringing the position to 30,613 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #2838.

Deutsche Bank first reported a position in DSGN in Q2 2021 and has held it in 20 quarters since. 36 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Deutsche Bank held 30,613 shares of Design Therapeutics worth $443K as of Q2 2026.
  • Deutsche Bank bought 9,969 Design Therapeutics shares in Q2 2026, an estimated $124K.
  • Design Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2838 holding.
  • Deutsche Bank first reported a position in Design Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 36 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.